Back to Ovarian Cancer
NCT00216645
NCT00216645
Who may be able to join
Who might be able to join this trial:
- You have ovarian cancer that responded to your first treatment but then came back within 12 months.
- You have received one or two rounds of chemotherapy for your ovarian cancer.
- Your cancer can be measured on scans, you are in reasonably good general health, and your major organs (such as your heart, liver, and kidneys) are working well enough (confirm with trial site).
Who may not be able to join:
- You have another illness or condition that could interfere with the study or affect how the treatment works in your body (confirm with trial site).
- You currently have an infection that has spread through your body.
- You have another active cancer in addition to your ovarian cancer.
- You have a build-up of fluid around your lungs or in your abdomen that needs to be drained on an ongoing basis.
- You have fluid around your heart that needs to be drained.
- You have had a heart attack or chest pain (angina) within the last 90 days before joining the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
Janssen Pharmaceutical K.K.
Registry
clinicaltrials_gov
Start date
1 January 2005
Primary endpoints
Overall response rate as antitumor effect (tumor shrinkage)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.